We previously published the performance evaluation of an automated electroencephalography (EEG)-based single-channel sleep-wake detection algorithm called Z-ALG used by the Zmachine ® sleep monitoring system. The objective of this paper is to evaluate the performance of a new algorithm called Z-PLUS, which further differentiates sleep as detected by Z-ALG into Light Sleep, Deep Sleep, and Rapid Eye Movement (REM) Sleep, against laboratory polysomnography (PSG) using a consensus of expert visual scorers. Methods: Single night, in-lab PSG recordings from 99 subjects (52F/47M, 18-60 years, median age 32.7 years), including both normal sleepers and those reporting a variety of sleep complaints consistent with chronic insomnia, sleep apnea, and restless leg syndrome, as well as those taking selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor antidepressant medications, previously evaluated using Z-ALG were re-examined using Z-PLUS. EEG data collected from electrodes placed at the differential-mastoids (A 1 -A 2 ) were processed by Z-ALG to determine wake and sleep, then those epochs detected as sleep were further processed by Z-PLUS to differentiate into Light Sleep, Deep Sleep, and REM. EEG data were visually scored by multiple certified polysomnographic technologists according to the Rechtschaffen and Kales criterion, and then combined using a majority-voting rule to create a PSG Consensus score file for each of the 99 subjects. Z-PLUS output was compared to the PSG Consensus score files for both epoch-by-epoch (eg, sensitivity, specificity, and kappa) and sleep stage-related statistics (eg, Latency to Deep Sleep, Latency to REM, Total Deep Sleep, and Total REM 
Introduction
Sleep-wake and sleep cycle estimation is of interest to both clinical applications and scientific studies. Overnight polysomnography (PSG), which uses electroencephalography (EEG), electrooculography, and electromyography (EMG) with visual analysis for sleep staging is considered the gold standard methodology for evaluating sleep indices. PSG is commonly used for the assessment and management of many sleep 
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Wang et al disorders; however, PSG can be costly and burdensome in terms of technician support for sensor application/removal, overnight monitoring (for in-lab PSG), and manual record scoring, in addition to being intrusive for the patient due to the necessity of wearing multiple sensors on the scalp and face throughout the night. These factors often make PSG impractical for some applications, especially those in which repeated measurements are necessary, and/or time or budgets are constrained. Minimally invasive techniques using accurate automated scoring of physiological data for sleep categorization and diagnostics may be a preferable alternative.
Automated scoring of EEG data is a more cost-effective option that removes subjectivity inherent in manual scoring by a technician, 1 but despite greater attention being paid to the development and implementation of technology in recent years, considerable work remains to be done in terms of developing objective, valid, and reliable methods for computing sleep variables. 2 Of the limited research that has been done on automated scoring algorithms, a few demonstrate promising results. A recent study by Malhotra et al 3 evaluated an automated scoring system in which PSG data scored by a computer algorithm was compared against visual scoring by PSG technologists. The authors reported that their automatic system yielded results that were similar to those obtained by experienced technologists. However, their algorithm requires multiple channels of physiological data including EEG, chin EMG, and electrooculography.
In the past decade, single-channel EEG-based sleep staging algorithms have started to gain attention among researchers who have proposed a variety of potential scoring methods that are compared against visual scoring. [4] [5] [6] [7] [8] Single-channel systems place fewer limitations on patient movement, and can be more convenient for use in the ambulatory environment than those systems employing multiple channels. Berthomier et al 9 assessed the performance of their proprietary sleep scoring algorithm (automatic sleep EEG analysis) using EEG data (C Z -P Z ) from 15 healthy individuals and compared the results to manual scoring. The authors evaluated the agreement with manual scorers, and reported results similar to those obtained with algorithms using multiple channels of data.
A wireless, single-channel EEG system using data from the F P1 -F P2 channel for sleep staging was evaluated on 29 healthy adults and compared with visually scored data by two independent PSG technologists, 10 and Griessenberger et al 11 pointed out that this system has a specific weakness in detecting the wake state.
The performance of another single-channel system, 12 also using data from the F P1 -F P2 channel, was evaluated on 44 subjects, including those with normal sleep, and those with sleep-disordered breathing. Using majority agreement among PSG technologists, the authors describe the overall sleep staging performance, with similar results for detecting N2 (non-rapid eye movement stage 2) and Rapid Eye Movement (REM) sleep in a subsample population with mild to moderate obstructive sleep apnea.
While these examples of computerized scoring algorithms lend support to the notion that automated sleep staging from single-channel data may be a feasible alternative to the gold standard of multi-channel PSG with visual scoring, there are currently no commercial systems that are widely used for automated sleep stage determination.
We previously published the performance evaluation of an automatic single-channel sleep-wake detection algorithm, Z-ALG, 13 which is currently used by the Zmachine ® , a commercially available, FDA-cleared, single-channel (A 1 -A 2 ) EEG-based sleep monitoring system intended for in-home use. The A 1 -A 2 EEG channel is not typically used as a signal source for sleep staging. However, because A 1 -A 2 is located completely outside of the hairline, it allows for easy patient self-application and removal of the sensors. Furthermore, A 1 -A 2 is located away from the face making it comfortable and unobtrusive to wear during sleep, and eliminates the possibility of leaving noticeable marks on the face and forehead. 13 To the best of our knowledge, this paper is the first to evaluate the performance of an algorithm that uses data from the A 1 -A 2 EEG location for automated sleep staging.
Methods Participants
The Mercy Medical Center Institutional Review Board (IRB) in Canton, OH, USA, approved all study procedures. As reported in our previous paper, 13 overnight in-lab PSG was conducted with 106 paid volunteers at Consolidated Research, Inc. (CRI) in Cleveland, OH, USA, in 2003. Of those 106, a total of 99 records were used for our analyses: technical issues with the PSG recording system excluded four records, lack of technician adherence to protocol excluded two records, and one individual withdrew their participation.
Participants were screened for eligibility by research staff through structured telephone interviews and questionnaires. There were 52 females and 47 males, between the ages of 18 and 60 years (median age: 32.7 years), participating in the study. In order to increase ecological validity and 103 evaluation of Z-PlUS generalizability of results from the study sample, exclusion criteria were minimal, allowing for the inclusion of individuals reporting both normal sleep, and those reporting symptoms consistent with various sleep disorders such as chronic insomnia, sleep apnea, and restless leg syndrome.
Applicants were categorized according to the American Society of Anesthesiologists (ASA) 14 physical status classification system. Applicants with ASA physical status 1 (normal, healthy), 2 (mild systemic disease), and 3 (severe systemic disease) were eligible for inclusion; however, there were no participants meeting ASA physical status 3 in the study cohort.
Individuals were excluded for age less than 18 years, current pregnancy, and reporting skin sensitivity. Medications know to affect EEG morphology were exclusionary, except selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) which were included in an attempt to determine their possible impact on algorithm accuracy.
As described in our previous paper, 13 sleep disturbances were reported by 50 of the 99 study participants (50.5%), including:
• Thirty-five participants (35.4%) reported symptoms consistent with at least one variety of chronic insomnia (sleep onset, sleep maintenance, and waking too early) defined as 30-minute sleep onset latency (n=25, 25.3%), 30-minute Wake after Sleep Onset (n=13, 13.1%), or waking earlier than desired (n=12, 12.1%) with an inability to return to sleep occurring at least three times per week and persisting for at least 4 weeks. Of those 35 participants, 15 reported symptoms consistent with multiple types of chronic insomnia (ie, onset and maintenance, onset and early waking, or maintenance and early waking).
• Twenty-two participants (22.2%) reported strange leg sensations keeping them from falling asleep or staying asleep indicative of possible restless leg syndrome or periodic limb movements.
• Five participants (5.1%) responded positively to both snoring and nocturnal cessation of breathing/choking indicative of possible sleep apnea.
laboratory PSg system and recordings
As described in Kaplan et al, 13 participant data were acquired using a PSG system developed by CRI to acquire highresolution (16-bit A/D conversion), wide bandwidth (0.5 Hz high-pass filter, 380 Hz low-pass filter, 2.5 kHz sampling frequency), and low noise signals (∼4 µVpp input-referred noise floor, ±500 µV non-distorted input range). Acquired signals included: EMG, LOC, ROC, C 3 -A 2 , C 4 -A 1 , O 1 -A 2 , F P1 -F P2 , A 1 -A 2 , finger-probe pulse-oximetry, and timestamped video/audio recording (EEG channels A 1 -A 2 and F P1 -F P2 were acquired and archived, but were not used for subsequent visual scoring). The EEG channel A 1 -A 2 was the only data source used by Z-ALG and Z-PLUS.
Visual sleep scoring and epochby-epoch consensus PSG data were visually scored in accordance with the sleep industry standard of Rechtschaffen and Kales 15 that has also been used to evaluate many of the automated scoring systems previously described. Certified polysomnographic technologists conducted visual scoring of PSG data in 30-second epochs to identify the sleep stage (ie, Wake, 1, 2, 3, 4, REM, or unknown) and any arousals. A score of "unknown" was assigned when either the participant was disconnected from the PSG system, or the waveforms were ambiguous or unclear.
In order to allow for consensus scoring of each epoch, all PSG records were scored by two or more PSG technologists (three records were scored by two technologists, 16 records scored by three technologists, and 80 records scored by four technologists), with each of the five technologists (T1-T5) scoring the following number of records: T1 scored 97 records, T2 scored 38 records, T3 scored 98 records, T4 scored 42 records, and T5 scored 99 records. Each epoch was assigned a sleep stage based upon a majority agreement rule (PSG Consensus), and these data were used as the standard against which Z-PLUS was evaluated. If there was no consensus between technologists on a particular epoch, the epoch was not included.
Sleep staging algorithm (Z-PlUS)
The Z-PLUS algorithm evaluated in this paper further differentiates epochs identified as sleep by Z-ALG into Light Sleep, Deep Sleep, and REM as shown in Figure 1 . The performance of Z-PLUS was evaluated against the same 99-subject data set as used to evaluate the wake-sleep detection performance of Z-ALG. 13 Both Z-PLUS and Z-ALG use EEG data acquired from the contralateral area of the mastoid process located behind the ears, termed A 1 -A 2 , with a signal common (COM) located on the back of the neck or shoulder, as shown in Figure 2 . A schematic representation of Z-PLUS is depicted in Figure 3 
Statistical analysis
In accordance with recommendations by Berthomier and Brandewinder, 2 statistical measures of agreement, sensitivity, and positive predictive value (PPV) were calculated to assess the performance of Z-PLUS. Cohen's kappa was used to quantify inter-rater reliability of the visual scoring by pairs of technologists for each study participant, and to evaluate the Z-PLUS versus the PSG Consensus. Cohen's kappa statistic quantifies the agreement between two raters beyond what would be expected from chance alone for categorical data. Although there is no formally agreed upon standard, kappa scores are commonly segmented into ranges of values that are indicative of less than chance agreement (kappa ,0), slight agreement (0# kappa ,0.2), fair agreement (0.2# kappa ,0.4), moderate agreement (0.4# kappa ,0.6), substantial agreement (0.6# kappa ,0.8), and almost perfect agreement (0.8# kappa ,1).
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Sensitivity and PPV were calculated for the Z-PLUS sleep staging determination versus the PSG Consensus sleep staging assignments. When the PSG Consensus assigns an epoch to a particular stage of sleep, the sensitivity of that stage describes the probability that Z-PLUS will score that
REM. Z-PLUS determines
In addition to time domain features TF1 and TF2, and frequency domain feature FF3, all of which were computed and used by Z-ALG, a new frequency domain feature FF4 that also falls within the conventionally defined delta (δ) band is computed and used by Z-PLUS. Z-PLUS computes two additional scale values used to separate REM and Deep Sleep. Like the scale values used by Z-ALG, these additional scale values are computed for each individual, based on their data alone, and therefore inherently accounts for EEG signal differences among individuals.
As depicted in Figure 3 , the hierarchical detection scheme (detectors D3 and D4) is used first to determine REM, then Deep Sleep, and finally Light Sleep. To detect REM sleep, 
Results

comparison by sleep stage
To evaluate the accuracy of Z-PLUS, the PSG Consensus scores were combined to match the outputs of the Z-PLUS algorithm, such that PSG Consensus stages 1 and 2 were combined into Light Sleep, and stages 3 and 4 were combined into Deep Sleep. There are a total of 91,824 epochs (765 hours) of recorded data for the 99 subjects. Of those epochs, 85,206 epochs (92.8%) had majority agreement among the PSG technologist scores. For the purposes of this analysis, the PSG Consensus is considered to represent the true sleep state and the standard by which Z-PLUS is compared. 
Sensitivity and PPV
The sensitivity and PPV of Z-PLUS as compared with the PSG Consensus are summarized in Table 2 , and the sensitivity and PPV of Z-PLUS as compared with the individual PSG technologists are summarized in Table 3 .
The sensitivity and PPV are higher for the PSG Consensus of Table 2 Table 4 . It should be noted that the number of subjects in both the Apnea and SSRI/SNRI subgroups are too small to draw viable conclusions. They are listed here for completeness.
cohen's kappa analysis
Cohen's kappa statistic provides a method for quantifying the agreement between Z-PLUS and the PSG Consensus, each of which classified 85,206 epochs of data into Wake, Light Sleep, Deep Sleep, and REM. The kappa value for the sleep staging comparison described in Table 1 , across all 99 subjects, is 0.72, which indicates substantial agreement (0.6# kappa ,0.8) according to the classification given in Viera and Garrett. 16 The kappa scores among f ive PSG technologists (T1-T5) and Z-PLUS are shown in Table 5 . Technologists 
Bland-altman plots
To further demonstrate the agreement between Z-PLUS and the PSG Consensus, Bland-Altman plots were used to compare sleep statistics for their ability to reveal systematic biases and highlight outliers present between two data sets. BlandAltman plots displaying Total Sleep Time, Sleep Efficiency, Latency to Persistent Sleep, and Wake after Sleep Onset were provided in our previous publication. 13 In this paper, Bland Because different EEG channels, subject populations, and methods of analysis were used to evaluate each algorithm mentioned above, there is not sufficient uniformity to draw any concrete conclusions about the superiority of one technology over the other. To properly compare various algorithms, all algorithms must be evaluated using the same data and analyzed using a standardized methodology. It is clear, however, that Z-PLUS has poor agreement with PSG technologist T4 (see Table 3 ). Such discrepancy between individual raters supports the use of consensus scoring from two or more technologists as the standard against which algorithms such as Z-PLUS should be compared. Sensitivity and PPV values are lower for the detection of Deep Sleep and REM than for the detection of Light Sleep (see Tables 2-4) , which is consistent with the lower Pearson's correlations for the five sleep statistics provided with the Bland-Altman plots in Figures 5-9 versus the four sleep statistics published in our previous paper. 13 It might be the nature of the mastoid EEG channel A 1 -A 2 that makes Deep Sleep and REM detection more difficult to detect from a signal processing perspective. However, the A 1 -A 2 channel enables very comfortable use during sleep and is much less intrusive than other EEG locations, such as forehead or scalp EEG electrode locations. So far, to the best of our knowledge, Z-PLUS is the first algorithm to use A 1 -A 2 for sleep staging and based on the preliminary results presented in this paper, additional research is needed to further investigate the characteristics of the A 1 -A 2 EEG signal and to improve the accuracy of Z-PLUS.
A limitation of the present study is the classification of subgroups of sleep disorders according to self-reports rather than being clinically verified prior to inclusion in the study. Additionally, because subjects with particular symptom configurations or diagnoses were not specifically recruited, there are insufficient numbers of subjects in the sleep disorder subgroups to make any broad conclusions about the performance of Z-PLUS in such cases. However, the apnea and SSRI/SNRI subgroups do hint at somewhat degraded Z-PLUS performance especially in the detection of Deep Sleep. This may be the result of different characteristics of the EEG signal during Deep Sleep for these two subgroups versus other groups, where the performance of Z-PLUS for the insomnia and PLM/RLS subgroups was not negatively impacted. However, the study of larger sleep disordered populations using a variety of patient demographic types should be performed in the future to further understand the strengths and limitations of Z-PLUS, as well as to improve the performance of future versions of the algorithm.
Despite these limitations, our data suggest that Z-PLUS is an accurate automated scoring algorithm for identifying sleep stages both in normal sleepers and in individuals with certain sleep disturbances.
